(13)C CPMAS NMR spectroscopy has been employed to investigate the surface chemistry of the organotantalum hydrocarbyl/alkylidene complexes, Cp'Ta((13)CH(3))(4) (1*), Cp(2)Ta((13)CH(3))(3) (2*), Cp(2)Ta((13)CH(2))((13)CH(3)) (3*), and Ta((13)CH(t)Bu)((13)CH(2)(t)Bu)(3) (4*) [Cp' = eta(5)-(CH(3))(5)C(5), Cp = eta(5)-C(5)H(5)] supported on partially dehydroxylated silica (PDS), dehydroxylated silica (DS), or dehydroxylated gamma-alumina (DA). Mono-Cp tantalum hydrocarbyl 1* undergoes chemisorption to form Cp'Ta((13)CH(3))(3)O-Si mu-oxo species on silica, and "cation-like" Cp'Ta((13)CH(3))(3)(+) and Cp'Ta((13)CH(3))(3)O-Al mu-oxo species on DA, via pathways analogous to those established for organo-group 4 and actinide complexes. When supported on DA, bis-Cp tantalum hydrocarbyl 2* follows the same chemisorption mode as 1*. However, when 2* is chemisorbed on PDS and DS, a "cation-like" Cp(2)Ta((13)CH(3))(2)(+) species is the major adsorbate product. On PDS, bis-Cp tantalum alkylidene complex 3* is converted predominantly to a stable "cation-like" Cp(2)Ta((13)CH(3))(2)(+) species, presumably via electrophilic addition of a proton from the PDS surface. In contrast to 3*, Ta alkylidene complex 4* forms predominantly a Ta((13)CH(t)Bu)((13)CH(2)(t)Bu)(2)O-Si, mu-oxo-alkylidene species on PDS.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: